Subscribe on Apple Podcasts Subscribe on Spotify
Show Notes

The Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics.  Slam Bio is developing a platform of first-in-class monoclonal antibody therapies and antibody-drug conjugates (ADCs) targeting cancer, beginning with blood cancers.

The conversation took place at the BIO International Conference 2024 in San Diego June 4-6, 2024.

slambio.com

 

Listen to more of The Commons Podcast Episodes

Podcast
Season 4, Episode 22: Unlocking the Future of Medicine: A Conversation with Nobel Laureate Dr. Drew Weissman and Dr. Jim Hoxie of The Penn Institute for RNA Innovation
Podcast
Season 4, Episode 21: Talent for Today and Tomorrow: A Conversation with Career Expert Julie Bauke
Podcast
Season 4, Episode 20: The Commons Live from BIO International 2024 – Venture Capital Update: A Conversation with Illumina Ventures Partner, Mara Aspinall
Podcast
Season 4, Episode 19: The Commons Live from BIO International 2024 – Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics
Podcast
Season 4, Episode 18: The Commons Live from BIO International 2024 – A Conversation with Dr. Steven Lester and Dr. Rahul Pannala of Mayo Clinic Arizona
Podcast
Season 4, Episode 17: The Commons Live from BIO International 2024 – The Phoenix Bioscience Core: A Conversation with Scarlett Spring
Podcast
Season 4, Episode 16: The Commons Live from BIO International 2024 – Phoenix Children’s Hospital Genomics Lab: A Conversation with Stacey Metzler
Podcast
Season 4, Episode 15: The Commons Live from BIO International 2024 – RoddyMedical: A Conversation with Pat Deno
Podcast
Season 4, Episode 14: The Commons Live from BIO International 2024 – A Conversation with Councilwoman Kesha Hodge Washington
Podcast
Season 4, Episode 13: The Commons Live from BIO International 2024 – Phoenix Is BIO: A Conversation with Phoenix Mayor Kate Gallego